John Devlin, PharmD, BCCCP, FCCP, MCCM


Department of Pharmacy and Health Systems Sciences, School of Pharmacy and Pharmaceutical Sciences

Office: R218TF

Email: [email protected]

Phone: 617-373-8171

View Résumé/CV

Dr. Devlin’s research that has been supported by more than $5 million in federal and industry funding and resulted in more than 200 peer-reviewed publications focuses on the detection, prevention and treatment of delirium and disrupted sleep in the ICU and the pharmacoepidemiology of delirium in critically ill adults. In addition to his roles at Northeastern, he is a critical care pharmacist and Associate Scientist in the Division of Pulmonary and Critical Care Medicine at Brigham and Women’s Hospital and an Instructor of Medicine at Harvard Medical School, Boston, MA. He has mentored multiple ICU pharmacists through a long-standing Northeastern critical care fellowship/PhD program. Dr. Devlin chaired SCCM’s 2018 PADIS guidelines and served as panel member for ATS’s recent ICU sleep research task force. He currently serves as a NIDUS co-investigator; co-directing the dissemination core and its annual research bootcamp. He is a member of the editorial boards of Critical Care Medicine and Pharmacotherapy and is a past president of the American Delirium Society 


Post-doctoral research fellow, Henry Ford Hospital, Detroit, MI
Practice Residency, London Health Sciences Center, London, CA
Doctor of Pharmacy, University of Toronto
Bachelors of Science in Pharmacy, University of Toronto


Critical Care

Research Interests:

Intensive Care, Delirium, Sedation, Sleep

Selected Honors and Awards:

Master of Critical Care Medicine  
Society of Critical Care Medicine – 2020 Fellow 
American College of Clinical Pharmacy – 2005 Fellow

Selected Publications:

Duprey MS, Dijkstra-Kersten SMA, Zaal IJ, Briesacher BA, Saczynski JS, Griffith, JL, Slooter AJC, Devlin JW. Opioid use increases the risk of delirium independently of pain in critically ill adults. Am J Respir Crit Care Med 2021;204(5):566-572  

Hughes C, Mailloux P, Devlin JW, et al. Dexmedetomidine vs. propofol for sedation in mechanically ventilated adults with sepsis. New Engl J Med 2021; 384(15):1424-1436.   

Devlin JW, Skrobik Y, Gelinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the intensive care unit. Crit Care Med 2018; 46(9):e825-e873.  

Mehta S, Burry L, Cook D, Fergusson D, Steinburg M, Granton J, Herridge M, Ferguson N, Devlin JW. A randomized trial of daily sedative interruption in mechanically ventilated critically ill patients cared for with a sedation protocol. JAMA 2010;308(19):1985-92.  

Devlin, JW, Roberts R, Fong JJ, et al. Efficacy and safety of quetiapine for delirium in the ICU: A randomized, doubleblind, placebo- controlled pilot study. Crit Care Med 2010. Feb;38(2):419-27 

Personal Links: